ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS
11 avr. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro gibt exklusive mehrjährige Lizenzvereinbarung mit UCSF für innovative intrazerebrale Zellverabreichungsplattform bekannt
28 mars 2023 17h57 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Kalifornien, March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (das „Unternehmen“), ein weltweites Unternehmen für therapieermöglichende Plattformen, das die...
ClearPoint Neuro annonce un accord de licence exclusif pluriannuel avec l'UCSF concernant une plateforme innovante pour l'administration cellulaire intracérébrale
28 mars 2023 17h57 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californie, 28 mars 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT) (la « Société »), une société mondiale de plateformes thérapeutiques permettant la navigation et...
ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform
28 mars 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results
01 mars 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023
15 févr. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue
11 janv. 2023 08h00 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden
12 déc. 2022 09h15 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Present at Upcoming Investor Conferences
09 nov. 2022 09h25 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports Third Quarter 2022 Results
08 nov. 2022 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...